Longhorn Vaccines to Present at IDWeek 2024
Longhorn Vaccines and Diagnostics, a notable player in the realm of public health innovation, plans to present groundbreaking data on two of its pioneering vaccine candidates at IDWeek 2024. This prestigious event will be held in Los Angeles, where professionals gather to share insights and advancements in infectious disease research and treatments.
Focus on Influenza and Antimicrobial Resistance
Longhorn is dedicated to addressing significant health threats imposed by seasonal influenza and antimicrobial resistance (AMR). Their innovative approach includes the development of LHNVD-110, an ambitious single peptide universal influenza vaccine that aims to provide broad protection across various strains. Simultaneously, their LHNVD-303 candidate targets AMR by utilizing a strategic blend of lipoteichoic acid, lipopolysaccharide, and peptidoglycan, designed to combat bacteria that are resistant to conventional antibiotics.
Data Presentation Overview
During IDWeek 2024, Longhorn will unveil valuable insights from two critical abstracts that highlight their progress in vaccine development. These presentations promise to shed light on the efficacy of their innovative solutions in tackling pressing global health challenges.
Key Poster Presentations
The company is set to present the following notable posters at the event:
Poster Title: A Single Composite Peptide Vaccine Comprising Conserved Influenza Epitopes Formulated with ALFQ Adjuvant Induced Broadly Reactive Antibodies to Human, Avian, and Swine Influenza Viruses
Presenter: Clara J. Sei, MPH, Vice President of Vaccine and Antibody Development at Longhorn Vaccines & Diagnostics
Poster Session: Adult Vaccines
Session Date: Thursday, October 17, 2024
Session Time: 12:15 PM – 1:30 PM PST
Session Location: Halls JK, Los Angeles Convention Center
Poster Title: Developing Vaccines and Antibodies Targeting Conserved Peptidoglycan, Lipoteichoic Acid, and Lipopolysaccharide Epitopes to Combat Antimicrobial Resistance
Presenter: Nimisha Rikhi, Research Scientist at Longhorn Vaccines & Diagnostics
Poster Session: Novel Agents
Session Date: Friday, October 18, 2024
Session Time: 12:15 PM – 1:30 PM PST
Session Location: Halls JK, Los Angeles Convention Center
Understanding the Importance of IDWeek
IDWeek is a significant gathering for medical professionals focused on infectious diseases. This annual meeting brings together the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, and other key organizations to discuss advancements and shared challenges in the healthcare field.
About Longhorn Vaccines and Diagnostics
Longhorn Vaccines and Diagnostics is a dynamic One Health company committed to developing broad coverage vaccines and diagnostic tools aimed at combating global public health issues. The organization, founded in 2006, emphasizes the importance of building solutions that have a profound impact on emerging pandemics affecting both humans and animals.
Their flagship product, PrimeStore® Molecular Transport Medium, is an advanced FDA-cleared device designed to collect and transport samples at ambient temperature. This innovation not only facilitates safer handling of infectious disease samples but also ensures the preservation of RNA and DNA, thus enhancing diagnostic efficiency. By bridging the gap between diagnosis and treatment, Longhorn aims to empower healthcare systems and improve patient outcomes worldwide.
Frequently Asked Questions
What is the purpose of Longhorn's presentation at IDWeek 2024?
Longhorn aims to present their pioneering research on the universal influenza vaccine LHNVD-110 and the antimicrobial resistant sepsis vaccine LHNVD-303.
Where will IDWeek 2024 be held?
IDWeek 2024 will take place in Los Angeles, California, serving as a platform for professionals in infectious disease research to gather.
Why are AMR vaccines important?
AMR vaccines are critical due to the rising threat of antibiotic-resistant infections, which pose significant challenges to public health worldwide.
What distinguishes Longhorn's PrimeStore® MTM?
PrimeStore® MTM is unique as it can deactivate pathogens and stabilize genetic material, making it safer and more effective for molecular testing.
How long has Longhorn been in operation?
Longhorn Vaccines and Diagnostics has been operational since 2006, focusing on innovative solutions for public health challenges.